The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV

Chronic Obstructive Pulmonary Disease Clinical Trial

Official title:

The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea and Activity in Patients With COPD III-IV

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01478646
• Other study ID #: RAT 2011
• Secondary ID: KBerchtesgadener
• Status: Completed
• Phase: N/A
• First received: September 30, 2011
• Last updated: November 22, 2011
• Start date: August 2011
• Est. completion date: November 2011

Study information

• Verified date: November 2011
• Source: Klinikum Berchtesgadener Land der Schön-Kliniken
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea and increase activity.

Description:

In the treatment of COPD-Patients different kinds of breathing therapy techniques are used, but many of them are not reassessed yet.

Dyspnea is one of the predominant symptoms of COPD patients and has negative impacts on the activity of the patients. Dyspnea during exertion leads to avoiding activity and results in a deconditioning of muscles and of the cardiovascular system.

Thus breathing therapy techniques seem to be useful, which may lead to a decrease of dyspnea and an increase of activity.

The purpose of this study is to determine whether reflective breathing therapy is more effective on decreasing dyspnea and increasing activity than conventional breathing therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: November 2011
• Est. primary completion date: November 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 45 Years to 75 Years

Eligibility

Inclusion Criteria:

• inpatient rehabilitation

• COPD (Gold stage III and IV)

Exclusion Criteria:

• severe exacerbation in the last four weeks

• acute infections

• fever

• neuritides

• severe osteoporosis

• skin disease

• manic depression

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive
• Respiratory Aspiration

Intervention

Other:
• conventional breathing therapy
duration: 60 minutes.
• reflectory breathing therapy
duration: 60 minutes.

Locations

Country	Name	City	State
Germany	Schön Klinik Berchtesgadener Land	Schönau	Bayern

Sponsors (2)

Lead Sponsor	Collaborator
Klinikum Berchtesgadener Land der Schön-Kliniken	University of Osnabrueck

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in BORG-Scale	Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea).	Change from pre (minute o) in BORG-scale at directly post intervention (minute 60)	Yes
Secondary	Change in residual volume	measured by a portable spirometry device	change from pre (minute 0) in residual volume at post (minute 60) intervention	No